An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder
Clinical trial NCT00191516 · COMPLETED
Trial details
- NCT number
- NCT00191516
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.